Institut de Cancérologie de Lorraine

healthcare FR

Publications

2,673

Citations

Researchers

Publications

View All

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy , Pascal Hammel , Mohamed Hebbar +29 more

Adjuvant therapy with a modified FOLFIRINOX regimen led to significantly longer survival than gemcitabine among patients with resected pancreatic cancer, at the expense of a hig...

2018 New England Journal of Medicine 2673 citations

Affiliated Researchers

Thierry Conroy

Institut de Cancérologie de Lorraine

Institution Info

Type: healthcare
Country: FR
Publications: 1
Citations: 2,673

External Links

Identifiers

ROR: https://ror.org/00yphhr71